NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported a 9-percent increase in second-quarter revenues, including a 28-percent jump in revenues generated by its Specialty Diagnostics segment.

For the period ended June 30, total revenues came in at $3.11 billion, up from $2.85 billion a year ago. Wall Street had a consensus estimate of $3.05 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.